Biotech Finance
Dilution
Dilution is the reduction in existing shareholders’ ownership when a company issues new shares — commonly to raise cash through a secondary or at-the-market offering. Clinical-stage biotechs dilute frequently to fund trials, so investors watch financing risk closely.
- Category
- Biotech Finance
Prepared research question
How does Dilution affect the view of a biotech company in practice?
Traceable citations · Unknowns marked
Dilution is the reduction in existing shareholders’ ownership when a company issues new shares — commonly to raise cash through a secondary or at-the-market offering. Clinical-stage biotechs dilute frequently to fund trials, so investors watch financing risk closely.
Related terms
From term to thesis rule
Investigate how Dilution changes a biotech thesis
Define when Dilution should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.